Market Overview

40 Stocks Moving in Tuesday's Pre-Market Session

Share:
40 Stocks Moving in Tuesday's Pre-Market Session

Gainers

  • Westwater Resources, Inc. (NASDAQ: WWR) shares rose 54.6% to $12.80 in pre-market trading after jumping over 87% on Monday. The company holds minerals rights for lithium and uranium deposits and strength appears related to momentum in lithium names amid EV battery interest.
  • Axovant Gene Therapies Ltd. (NASDAQ: AXGT) rose 32.2% to $7.44 in pre-market trading after reporting positive six-month follow-up data from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD gene therapy.
  • Naked Brand Group Limited (NASDAQ: NAKD) shares rose 32.2% to $0.15 in pre-market trading as the company’s subsidiary, Bendon, entered into a settlement deal with Timothy Connell, William Gibson and Ivory Castle.
  • Xtant Medical Holdings, Inc. (NASDAQ: XTNT) rose 22.4% to $1.86 in pre-market trading. Xtant Medical shares climbed over 91% on Friday after the company announced the closing of debt restructuring.
  • Alteryx, Inc. (NYSE: AYX) rose 21% to $137.76 in pre-market trading after the company raised its sales guidance for the third quarter and announced Mark Anderson as new CEO.
  • Gamida Cell Ltd. (NASDAQ: GMDA) rose 20.2% to $5.05 in pre-market trading after the company announced its Phase 3 clinical study of Omidubicel met all three of its secondary endpoints.
  • Emerald Holding, Inc. (NYSE: EEX) shares rose 18.1% to $2.74 in pre-market trading after the company announced it authorized a $20 million buyback program.
  • Cemtrex, Inc. (NASDAQ: CETX) rose 16.5% to $1.34 in pre-market trading. Cemtrex recently appointed Priscilla Popov as CFO.
  • ChromaDex Corporation (NASDAQ: CDXC) rose 16% to $4.72 in pre-market trading. ChromaDex highlighted publicatoin of study results showing 'nutritional protocol including nicotinamide riboside plus standard of care reduces recovery time in COVID-19 patients by nearly 30%.'
  • MICT, Inc. (NASDAQ: MICT) rose 14.4% to $3.98 in pre-market trading. MICT's GFH Intermediate Holdings subsidiary, last week, reported it will purchase 9% interest in Hong Kong-based securities and investments firm for $3 million.
  • Houston American Energy Corp. (NYSE: HUSA) rose 13.7% to $1.74 in pre-market trading.
  • DBV Technologies S.A. (NASDAQ: DBVT) rose 12.7% to $1.86 in pre-market trading.
  • BioNTech SE (NASDAQ: BNTX) rose 11.5% to $89.99 in pre-market trading. BioNTech and Pfizer reported the initiation of rolling submission to the EMA for SARS-CoV-2 vaccine candidate BNT162b2.
  • Livent Corporation (NASDAQ: LTHM) rose 10.7% to $12.50 in pre-market trading after surging over 18% on Monday.
  • Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) rose 10.4% to $14.01 in pre-market trading. Alphabet and Sequoia-backed insurance startup Clover Health plans to go public via a merger with blank check company Social Capital Hedosophia Holdings Corp. III, reports the New York Times.
  • CBAK Energy Technology, Inc. (NASDAQ: CBAT) rose 9.4% to $4.54 in pre-market trading. CBAK Energy Technology shares climbed around 33% on Monday amid continued volatility in the lithium and EV battery space.
  • Affimed N.V. (NASDAQ: AFMD) rose 8.8% to $3.85 in pre-market trading after the company announced that the first patient was dosed with allogeneic cord blood-derived natural killer cells preloaded with AFM13 and has moved on to the AFM13 monotherapy phase of the treatment cycle.
  • XpresSpa Group, Inc. (NASDAQ: XSPA) shares rose 8.4% to $2.45 in pre-market trading after gaining around 18% on Monday.
  • CHF Solutions, Inc.. (NASDAQ: CHFS) rose 6.9% to $0.4007 in pre-market trading after gaining around 4% on Monday.
  • Tata Motors Limited (NYSE: TTM) rose 6.6% to $9.81 in pre-market trading.
  • Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6% to $1.79 in pre-market trading. Allena Pharmaceuticals, last week, announced a $25 million strategic convertible debt financing agreement with Pontifax Ventures.
  • GlycoMimetics, Inc. (NASDAQ: GLYC) rose 5.8% to $3.46 in pre-market trading after the company announced the FDA granted the company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle cell disease in patients 18 years old and younger.
  • Himax Technologies, Inc. (NASDAQ: HIMX) rose 5.5% to $3.65 in pre-market trading following strong preliminary results for the third quarter.
  • U.S. Well Services, Inc. (NASDAQ: USWS) rose 5.3% to $0.2790 in pre-market trading.
  • Spartan Energy Acquisition Corp. (NYSE: SPAQ) rose 5% to $14.96 in pre-market trading. Spartan Energy Acquisition and Fisker set October 28, 2020 special meeting to approve their merger.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Miragen Therapeutics, Inc. (NASDAQ: MGEN) fell 25% to $0.5701 in pre-market trading after the company announced that it conducted an internal review of preliminary topline data from its Phase 2 SOLAR clinical trial of cobomarsen in patients with Cutaneous T-Cell Lymphoma. The press release said preliminary data in 37 patients suggest that cobomarsen lacks a compelling result for the study's primary endpoint.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares fell 20% to $25.65 in pre-market trading after the company reported it and the FDA "have not been able to agree on the required potency assays to fully define its TIL therapy." The company said BLA submission for Lifileucel is now anticipated for 2021.
  • Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) shares fell 18.6% to $33.95 in pre-market trading after the company reported it received a Refusal to File letter from the FDA regarding the Biologics License Application for omburtamab for the treatment of patients with neuroblastoma.
  • Artelo Biosciences, Inc. (NASDAQ: ARTL) fell 13.8% to $0.94 in pre-market trading after surging over 26% on Monday. Artelo Biosciences, last week, received Ethics Committee approval in the UK to commence its Phase I/II study of ART27.13.
  • Surgalign Holdings, Inc. (NASDAQ: SRGA) shares fell 13.1% to $1.60 in pre-market trading. Surgalign Holdings, last week, announced an agreement to acquire Holo Surgical and its ARAI digital surgery platform for $30 million in cash plus 6.25 million shares of common stock.
  • Greenpro Capital Corp. (NASDAQ: GRNQ) shares fell 12.4% to $1.63 in pre-market trading. Greenpro Capital shares jumped over 70% on Monday after the company reported it intends to incubate a satellite communication venture.
  • Pacific Drilling S.A. (NYSE: PACD) fell 11.9% to $0.26 in pre-market trading after rising 5% on Monday.
  • Inpixon (NASDAQ: INPX) fell 7.3% to $1.14 in pre-market trading. Inpixon yesterday announced plans to buy Nanotron for $8.7 million.
  • Logitech International S.A. (NASDAQ: LOGI) fell 7% to $75.10 in pre-market trading. Logitech is expected to release quarterly earnings on October 19.
  • LM Funding America, Inc. (NASDAQ: LMFA) fell 6.2% to $0.5620 in pre-market trading after declining around 8% on Monday.
  • Kosmos Energy Ltd. (NASDAQ: KOS) fell 6.2% to $1.05 in pre-market trading after gaining 9% on Monday. Kosmos Energy recently reported closing of $200 million Gulf of Mexico facility.
  • Jaguar Health, Inc. (NASDAQ: JAGX) fell 6.1% to $0.2911 in pre-market trading. Jaguar Health recently signed an agreement for non-dilutive financing transaction involving sale of royalty rights related to future Mytesi revenue stream.
  • PIMCO Dynamic Income Fund (NYSE: PDI) fell 5.8% to $24.35 in pre-market trading after the company announced a public offering of 3 million shares of common stock.
  • Zealand Pharma A/S (NASDAQ: ZEAL) fell 5.4% to $42.56 in pre-market trading after rising over 7% on Monday.
  • Prudential Financial, Inc. (NYSE: PRU) fell 5.4% to $62.16 in pre-market trading.
 

Related Articles (AFMD + ALNA)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas